✦ LIBER ✦

A population-based study of gefitinib in patients with non-small cell lung cancer

✍ Scribed by Kenji Hayashibara; Hiroaki Satoh; Yoko Shinohara; Masaharu Inagaki; Takayuki Kaburagi; Toshio Hashimoto; Koichi Kurishima; Hiroichi Ishikawa; Hideo Ichimura; Takeshi Nawa; Yasunori Funayama; Takeshi Matsumura; Katsunori Kagohashi; Takeshi Endo; Kinya Furukawa; Koji Kishi; Masaaki Sumi; Koichi Kamiyama; Shigemi Ishikawa

Book ID: 107576741
Publisher: Springer US
Year: 2008
Tongue: English
Weight: 224 KB
Volume: 26
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-008-9110-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvements of quality of life in patie

Improvements of quality of life in patients with advanced non-small cell lung cancer treated with gefitinib

✍ Yanmei Zou; Hua Xiong; Shiying Yu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 76 KB

Elevation of soluble interleukin-2 recep

Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib

✍ Shigenori Kanazawa; Kazuyuki Yamaguchi; Yoshimi Kinoshita; Yutaka Komiyama; Miki 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 297 KB

Thoracic Radiotherapy and Concurrent Gef

Thoracic Radiotherapy and Concurrent Gefitinib in Patients with IIIB/IV Non–small Cell Lung Cancer (NSCLC): Phase I Study

✍ Zhang, G.; Xie, L.; Xu, X.; Chen, J.; Fu, X.; Jiang, G.; Fan, M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Gefitinib in the treatment of 41 cases w

Gefitinib in the treatment of 41 cases with refractory non-small cell lung cancer

✍ Jianfang Xu; Caicun Zhou; Aiwu Li 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 76 KB

Establishment of a human non-small cell

Establishment of a human non-small cell lung cancer cell line resistant to gefitinib

✍ Fumiaki Koizumi; Tatsu Shimoyama; Fumiko Taguchi; Nagahiro Saijo; Kazuto Nishio 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 672 KB

## Abstract The epidermal growth factor receptor (EGFR) tyrosine‐kinase inhibitor gefitinib (Iressa®, ZD1839) has shown promising activity preclinically and clinically. Because comparative investigations of drug‐resistant sublines with their parental cells are useful approaches to identifying the m

Impact of functionalABCG2polymorphisms o

Impact of functionalABCG2polymorphisms on the adverse effects of gefitinib in Japanese patients with non–small-cell lung cancer

✍ Keiichi Akasaka; Takayuki Kaburagi; Shin’ichi Yasuda; Kyoko Ohmori; Kaori Abe; H 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 212 KB